Chemical Name: Exenatide acetate
CAS No.: 141732-76-5
Molecular Formula: C186H286N50O62S
Molecular Weight: 4244.60796
Chemical Name: Exenatide acetate
CAS No.: 141732-76-5
Molecular Formula: C186H286N50O62S
Molecular Weight: 4244.60796
Chemical Name: Exenatide acetate
CAS No.: 141732-76-5
Molecular Formula: C186H286N50O62S
Chemical Structure:
Molecular Weight: 4244.60796
Exenatide acetate Chemical Properties |
Melting point | >209°C (dec.) |
storage temp. | Refrigerator, under inert atmosphere |
solubility | Acetonitrile (Slightly), Water (Slightly) |
form | Solid |
color | White to Off-White |
Sequence | H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
Exenatide acetate is White Solid
A 39-amino acid peptide originally isolated from the salivary glands of the Gila monster (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide has found use as a medication of diabetes II.
Application of exenatide acetate causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acetate acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide acetate augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide acetate has found use as a medication of diabetes II.
39-peptide known as an incretin mimetic; an agonist of glucagon-like peptide-1, used adjunctively in type II diabetes mellitus.
Potentially hazardous interactions with other drugs
Anticoagulants: possibly enhances anticoagulant effect of warfarin.
Other nephrotoxins: avoid concomitant use.
Exenatide is eliminated through the kidneys by glomerular filtration followed by proteolytic degradation.